Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2018 (725 publications)

no pagination
Morrison C, Pabla S, Conroy JM, Nesline MK, Glenn ST, Dressman D, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Qin M, Wang Y, Lenzo FL, Omilian A, Bshara W, Zibelman M, Ghatalia P, Dragnev K, Shirai K, Madden KG, Tafe LJ, Shah N, Kasuganti D, de la Cruz-Merino L, Araujo I, Saenger Y, Bogardus M, Villalona-Calero M, Diaz Z, Day R, Eisenberg M, Anderson SM, Puzanov I, Galluzzi L, Gardner M, Ernstoff MS. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden. Journal for immunotherapy of cancer. 2018 May 09;6(1):32.   PMCID: PMC5944039
Mortazavi SM. Shortcomings of the immunological model of carcinogenesis. Proc Natl Acad Sci U S A. 2018 May 08;115(19):E4318.   PMCID: PMC5949006
Churilla TM, Weiss SE. Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer. Current oncology reports. 2018 May 07;20(7):54.   PMCID: Review
Di Meco A, Li JG, Barrero C, Merali S, Pratico D. Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy. Mol Psychiatry. 2018 May 04;.   PMCID: PMC6215750
Anari F, O'Neill J, Choi W, Chen DY, Haseebuddin M, Kutikov A, Dulaimi E, Alpaugh RK, Devarajan K, Greenberg RE, Bilusic M, Wong YN, Viterbo R, Hoffman-Censits JH, Lallas CD, Trabulsi EJ, Smaldone M, Geynisman DM, Zibelman M, Lin J, Kelly WK, Uzzo R, McConkey D, Plimack ER. Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial. European urology oncology. 2018 May;1(1):54-60.   PMCID: PMC6226048
Borghaei H, Yim YM, Guerin A, Pivneva I, Shi S, Gandhi M, Ionescu-Ittu R. Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy. Lung Cancer. 2018 May;119:112-9.
Buller DB, Heckman CJ, Manne SL. The Potential of Behavioral Counseling to Prevent Skin Cancer. JAMA dermatology. 2018 May;154(5):519-21.
Carqueijeiro I, Duge de Bernonville T, Lanoue A, Dang TT, Teijaro C, Paetz C, Billet K, Mosquera A, Oudin A, Besseau S, Papon N, Glevarec G, Atehortua L, Clastre M, Giglioli-Guivarc'h N, Schneider B, St-Pierre B, Andrade RB, O'Connor SE, Courdavault V. A BAHD acyltransferase catalyzing 19-O-acetylation of tabersonine derivatives in roots of Catharanthus roseus enables combinatorial synthesis of monoterpene indole alkaloids. The Plant journal : for cell and molecular biology. 2018 May;94(3):469-84.
Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw. 2018 May;16(5):479-90.
Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol. 2018 May;199(5):1238-44.
Cuttler JM, Mortazavi SM, Welsh JS, Doss M. Comments on "Low-Dose Childhood Radiation Effects to the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years after Exposure" Clin Thyroidol 2017;29:235-236). Thyroid : official journal of the American Thyroid Association. 2018 May;28(5):679-80.
Ebersole B, Soni RS, Moran K, Lango M, Devarajan K, Jamal N. The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence. Journal of voice : official journal of the Voice Foundation. 2018 May;32(3):325-31.
Fanale MA, Horwitz SM, Forero-Torres A, Bartlett NL, Advani RH, Pro B, Chen RW, Davies A, Illidge T, Uttarwar M, Lee SY, Ren H, Kennedy DA, Shustov AR. Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas. Blood. 2018 May;131(19):2120-4.   PMCID: PMC5946765
Fang CY, Tseng M. Ethnic density and cancer: A review of the evidence. Cancer. 2018 May;124(9):1877-903.   PMCID: PMC5920546
Forastiere AA, Fisher SG, Wolf GT. Reply to L. Licitra et al. J Clin Oncol. 2018 May;36(13):1377-8.
Gerson JN, Ramamurthy C, Borghaei H. Managing adverse effects of immunotherapy. Clinical advances in hematology & oncology : H&O. 2018 May;16(5):364-74.   PMCID: Review
Geynisman DM, Abbosh PH, Plimack ER, Zibelman M. Chemoimmunotherapy in Metastatic Urothelial Carcinoma. Eur Urol. 2018 May;73(5):760-2.   PMCID: Editorial
Halpern MT, Urato MP, Lines LM, Cohen JB, Arora NK, Kent EE. Healthcare experience among older cancer survivors: Analysis of the SEER-CAHPS dataset. Journal of geriatric oncology. 2018 May;9(3):194-203.   PMCID: PMC6002869
Heckman CJ, Handorf E, Auerbach MV. Prevalence and Correlates of Skin Cancer Screening Among Indoor Tanners and Nontanners. JAMA dermatology. 2018 May;154(5):554-60.   PMCID: PMC6128499
Kasivisvanathan V, Kutikov A, Manning TG, McGrath J, Resnick MJ, Sedelaar JP, Silay MS. Safeguarding the Future of Urological Research and Delivery of Clinical Excellence by Harnessing the Power of Youth to Spearhead Urological Research. Eur Urol. 2018 May;73(5):645-7.   PMCID: Editorial
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2018


Last updated on Thursday, May 02, 2019